Agreed, one of the side benefits of MSB trial will be some decent insight into the cohort group. How traditionally to treated patients fair at various endpoints. Data and stats to date have been rubbish and led to so much misinformation around ARDS and CoVID.
MSB Trading - 2020, page-17863
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.020(1.73%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.21 | $1.17 | $3.839M | 3.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 37228 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 59101 | 7 |
View Market Depth
| Last trade - 10.51am 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.19 |
Change
0.020 ( 3.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.21 | $1.21 | $1.17 | 639281 | ||
| Last updated 11.10am 07/05/2024 ? | |||||
| MSB (ASX) Chart |